Douglas P. Zipes MD
Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IndianaDr. Douglas P. Zipes is Distinguished Professor, Professor Emeritus of Medicine, Pharmacology and Toxicology, and Emeritus Director of the Division of Cardiology and Krannert Institute of Cardiology at Indiana University School of Medicine. He received his medical degree from Harvard Medical School and trained at Duke University Medical Center in medicine and cardiology. He joined Indiana University in 1970, became Distinguished Professor in 1994, and then Director of Cardiology (1995–2004).
Having published almost 1000 medical articles and 16 textbooks with multiple editions, Dr. Zipes is the recipient of numerous awards from the American Heart Association, the Heart Rhythm Society, the American College of Cardiology, and the European Society of Cardiology, among other professional societies and institutions.
He is past president of the American College of Cardiology and the Heart Rhythm Society, and past chair of the American Board of Internal Medicine. He is a fellow of the Heart Rhythm Society, American Heart Association, European Society of Cardiology. He is Master of the American College of Physicians and American College of Cardiology, and he is a member of the American Society for Clinical Investigation and the Association of American Physicians. In addition, Dr. Zipes retains honorary membership in the Cardiac Society of Australia and New Zealand, Argentine Society of Cardiology, Hungarian Society of Cardiology, and Israel Heart Society.
Recent Contributions to PracticeUpdate:
- ESC 2014: Hot Line Picks in Coronary Artery Disease and Atrial Fibrillation
- ESC 2014: Recommendations From the Editorial Board of PracticeUpdate Cardiology
- Increased Mortality Associated With Digoxin in Contemporary Patients With Atrial Fibrillation
- Sustained Ventricular Tachyarrhythmias Within 48 Hours of Acute MI: When Is ICD Appropriate?
- LVEF After Acute MI: Implications for Implantable Defibrillator Eligibility
- Update on Catheter Ablation of Atrial Fibrillation
- Epilepsy and Use of Antiepileptic Medications Associated With Increased Risk for SCD
- Effect of Resuming Chest Compression After Successful Defibrillation on VF Recurrence
- Prognosis in Brugada Syndrome Based on Class II Indication for ICD
- Atrial Fibrillation in Patients With Cryptogenic Stroke